XML 11 R50.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Derivative And Other Hedging Financial Instruments (Gain And Loss Activity On Derivative Financial Instruments Designated As Effective Hedge) (Details) (Derivatives Designated As Effective Hedges [Member], USD $)
In Millions
3 Months Ended 6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
Cash Flow Hedges [Member]
       
Recognized in OCI (effective portion) $ (6.9) [1] $ 4.5 [1] $ (14.2) [1] $ 7.8 [1]
Reclassified from AOCI to Income (7.5) (2.8) (10.6) (5.1)
Recognized in Income (2.3) [2] (0.3) [2] (5.6) [2] (1.0) [2]
Cash Flow Hedges [Member] | Foreign Currency Contracts [Member]
       
Recognized in OCI (effective portion) (2.6) [1] 0.4 [1] (11.7) [1] 2.0 [1]
Reclassified from AOCI to Income (7.5) (3.3) (10.6) (6.6)
Recognized in Income (2.3) [2] (0.3) [2] (5.6) [2] (1.0) [2]
Cash Flow Hedges [Member] | Interest Rate Swaps [Member]
       
Recognized in OCI (effective portion) (4.3) [1] 4.1 [1] (2.5) [1] 5.8 [1]
Reclassified from AOCI to Income   0.5   1.5
Recognized in Income   [2]   [2]   [2]   [2]
Gain (Loss) On Derivatives [Member] | Net Sales [Member]
       
Reclassified from AOCI to Income 0.1   (0.4) 0.4
Recognized in Income   [2]   [2]   [2]   [2]
Gain (Loss) On Derivatives [Member] | Cost of Sales [Member]
       
Reclassified from AOCI to Income (7.6) (3.3) (10.2) (7.0)
Recognized in Income   [2]   [2]   [2]   [2]
Gain (Loss) On Derivatives [Member] | SG&A [Member]
       
Reclassified from AOCI to Income        
Recognized in Income (2.3) [2] (0.3) [2] (5.6) [2] (1.0) [2]
Gain (Loss) On Derivatives [Member] | Interest Expense [Member]
       
Reclassified from AOCI to Income   0.5   1.5
Recognized in Income   [2]   [2]   [2]   [2]
Gain (Loss) On Derivatives [Member]
       
Reclassified from AOCI to Income (7.5) (2.8) (10.6) (5.1)
Recognized in Income $ (2.3) [2] $ (0.3) [2] $ (5.6) [2] $ (1.0) [2]
[1] Represents effective portion recognized in Other Comprehensive Income ("OCI").
[2] Represents portion excluded from effectiveness testing.